terconazole has been researched along with fluconazole in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Benrubi, GI; Griffin, CR; Magee, MJ; Parker, R; Slavin, MB | 1 |
| Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW | 1 |
| Cooper, CR; McGinnis, MR | 1 |
| Ringdahl, EN | 1 |
| Fan, S; Li, T; Liang, Y; Liu, X; Xu, H; Zhu, Y | 1 |
| Andreu, D; Cavalcante, CSDP; de Aguiar, FLL; Dos Santos Fontenelle, RO; Falcão, CB; Rádis-Baptista, G | 1 |
1 review(s) available for terconazole and fluconazole
| Article | Year |
|---|---|
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
2 trial(s) available for terconazole and fluconazole
| Article | Year |
|---|---|
Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Placebos; Suppositories; Tablets; Time Factors; Triazoles | 1992 |
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Treatment Outcome; Triazoles; Young Adult | 2015 |
5 other study(ies) available for terconazole and fluconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles | 1986 |
In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Osmolar Concentration; Triazoles | 1996 |
The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Peptide Fragments; Triazoles | 2020 |